Flagship explainer
What drives ABEONA THERAPEUTICS INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $71.2M | FY2025 |
| |
| Income before tax | $71.3M | FY2025 |
|
| Operating income | −$89.4M | FY2025 |
|
| $5.8M | FY2025 |
| |
| Ending assets | $220M | FY2025 |
|
| Beginning assets | $109M | FY2024 |
|
| $159M | FY2025 |
| |
| $44M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001493152-26-010413